Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: Results of an international multicentre study

Lupus

Volumn 26, Issue 3, 2017, Pages 266-276

  Amengual, O ^a   Forastiero, R ^b   Sugiura Ogasawara, M ^c   Otomo, K ^a   Oku, K ^a   Favas, C ^d   Delgado Alves, J ^d   Zigon P ^e   Ambrozic A ^e   Tomsic M ^e   Ruiz Arruza, I ^f   Ruiz Irastorza, G ^f   Bertolaccini, M L ^g   Norman, G L ^h   Shums, Z ^h   Arai, J ⁱ   Murashima, A ^j   Tebo, A E ^k   Gerosa, M ^l   Meroni, P L ^l   Rodriguez Pinto I ^m   Cervera, R ^m   Swadzba, J ⁿ   Musial, J ⁿ   Atsumi, T ^a   more..

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b FAVALORO UNIVERSITY   (Argentina)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^d HOSPITAL FERNANDO FONSECA   (Portugal)

^e UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^f HOSPITAL DE CRUCES   (Spain)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h INOVA DIAGNOSTICS INC   (United States)

ⁱ Medical & Biological Laboratories Co Ltd   (Japan)

^j NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^k ARUP LABORATORIES   (United States)

^l UNIVERSITY OF MILAN   (Italy)

^m UNIVERSITY OF BARCELONA   (Spain)

ⁿ JAGIELLONIAN UNIVERSITY   (Poland)

more..

Author keywords

Antiphospholipid antibodies; lupus anticoagulant; systemic lupus erythematosus; thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY; PROTHROMBIN ANTIBODY;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; CLINICAL EVALUATION; CLINICAL LABORATORY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ELISA KIT; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REPLICATION STUDY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; VEIN THROMBOSIS; ADOLESCENT; BLOOD; CLINICAL TRIAL; COMPLICATION; IMMUNOLOGY; INTERNATIONAL COOPERATION; MIDDLE AGED; MULTICENTER STUDY; PREGNANCY; PREGNANCY COMPLICATIONS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTERNATIONAL COOPERATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PHOSPHATIDYLSERINES; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THROMBOSIS; YOUNG ADULT;

EID: 85011547195     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203316660203     Document Type: Article

References (41)

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
2. Nayfe R, Uthman I, Aoun J, Saad Aldin E, Merashli M, Khamashta MA,. Seronegative antiphospholipid syndrome. Rheumatology (Oxford) 2013; 52: 1358-1367.
3. Arvieux J, Darnige L, Caron C, Reber G, Bensa JC, Colomb MG,. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulant. Thromb Haemost 1995; 74: 1120-1125.
4. Galli M, Beretta G, Daldossi M, Bevers EM, Barbui T,. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies. Thromb Haemost 1997; 77: 486-491.
5. Atsumi T, Ieko M, Bertolaccini ML, et al. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum 2000; 43: 1982-1993.
6. Tincani A, Morozzi G, Afeltra A, et al. Antiprothrombin antibodies: A comparative analysis of homemade and commercial methods. A collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA). Clin Exp Rheumatol 2007; 25: 268-274.
7. Bertolaccini ML, Atsumi T, Koike T, Hughes GR, Khamashta MA,. Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus. Thromb Haemost 2005; 93: 289-297.
8. Pengo V, Biasiolo A, Brocco T, Tonetto S, Ruffatti A,. Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies. Thromb Haemost 1996; 75: 721-724.
9. Vaarala O, Puurunen M, Manttari M, Manninen V, Aho K, Palosuo T,. Antibodies to prothrombin imply a risk of myocardial infarction in middle-aged men. Thromb Haemost 1996; 75: 456-459.
10. Horbach DA, van Oort E, Donders RC, Derksen RH, de Groot PG,. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies. Thromb Haemost 1996; 76: 916-924.
11. Forastiero RR, Martinuzzo ME, Cerrato GS, Kordich LC, Carreras LO,. Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies. Thromb Haemost 1997; 78: 1008-1014.
12. Palosuo T, Virtamo J, Haukka J, et al. High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men-a nested case-control study. Thromb Haemost 1997; 78: 1178-1182.
13. Bertolaccini ML, Atsumi T, Khamashta MA, Amengual O, Hughes GR,. Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. J Rheumatol 1998; 25: 1104-1108.
14. Galli M,. Should we include anti-prothrombin antibodies in the screening for the antiphospholipid syndrome? J Autoimmun 2000; 15: 101-105.
15. Donohoe S, MacKie IJ, Isenberg D, Machin SJ,. Anti-prothrombin antibodies: Assay conditions and clinical associations in the anti-phospholipid syndrome. Br J Haematol 2001; 113: 544-549.
16. Galli M, Luciani D, Bertolini G, Barbui T,. Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 2003; 102: 2717-2723.
17. Zanon E, Saggiorato G, Ramon R, Girolami A, Pagnan A, Prandoni P,. Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolism. Thromb Haemost 2004; 91: 255-258.
18. Tsutsumi A, Hayashi T, Chino Y, et al. Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: Clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays. Mod Rheumatol 2006; 16: 158-164.
19. Hoxha A, Ruffatti A, Pittoni M, et al. The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome. Clin Chim Acta 2012; 413: 911-913.
20. Galli M, Borrelli G, Jacobsen EM, et al. Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study. Blood 2007; 110: 1178-1183.
21. Sciascia S, Sanna G, Murru V, Roccatello D, Khamashta MA, Bertolaccini ML,. Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review. Thromb Haemost 2014; 111: 354-364.
22. Forastiero R, Martinuzzo M, Pombo G, et al. A prospective study of antibodies to beta2-glycoprotein I and prothrombin, and risk of thrombosis. J Thromb Haemost 2005; 3: 1231-1238.
23. Bizzaro N, Ghirardello A, Zampieri S, et al. Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: A 15-year longitudinal study. J Thromb Haemost 2007; 5: 1158-1164.
24. Atsumi T, Koike T,. Antiprothrombin antibody: Why do we need more assays? Lupus 2010; 19: 436-439.
25. Žigon P, Ambrožič A, Čučnik S, Kveder T, Rozman B, Božič B,. Modified phosphatidylserine-dependent antiprothrombin [corrected] ELISA enables identification of patients negative for other antiphospholipid antibodies and also detects low avidity antibodies. Clin Chem Lab Med 2011; 49: 1011-1018.
26. Žigon P, Čučnik S, Ambrožič A, Šodin Semrl S, Kveder T, Božič B,. Antibodies to phosphatidylserine/prothrombin complex as an additional diagnostic marker of APS? Lupus 2012; 21: 790-792.
27. Žigon P, Čučnik S, Ambrožič A, et al. Detection of antiphosphatidylserine/prothrombin antibodies and their potential diagnostic value. Clin Dev Immunol 2013; 2013: 724592.
28. Bertolaccini ML, Amengual O, Atsumi T, et al. 'Non-criteria' aPL tests: Report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010. Lupus 2011; 20: 191-205.
29. Bertolaccini ML, Amengual O, Andreoli L, et al. 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. Autoimmun Rev 2014; 13: 917-930.
30. Hoxha A, Ruffatti A, Tonello M, et al. Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome. Lupus 2012; 21: 787-789.
31. Bertolaccini ML, Sciascia S, Murru V, Garcia-Fernandez C, Sanna G, Khamashta MA,. Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine-prothrombin complex (aPS/PT) in patients with and without lupus anticoagulant. Thromb Haemost 2013; 109: 207-213.
32. Nojima J, Iwatani Y, Suehisa E, Kuratsune H, Kanakura Y,. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus. Haematologica 2006; 91: 699-702.
33. Tselios K, Sarantopoulos A, Gkougkourellas I, Boura P,. The role of anti-phosphatidylserine/prothrombin antibodies in thrombotic manifestations of systemic lupus erythematosus patients. Front Neurol 2013; 4: 66.
34. Zigon P, Perdan Pirkmajer K, Tomsic M, et al. Anti-Phosphatidylserine/Prothrombin antibodies are associated with adverse pregnancy outcomes. J Immunol Res 2015; 2015: 975704.
35. Galli M, Luciani D, Bertolini G, Barbui T,. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: A systematic review of the literature. Blood 2003; 101: 1827-1832.
36. Devreese K, Peerlinck K, Hoylaerts MF,. Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants. Blood 2010; 115: 870-878.
37. de Laat HB, Derksen RH, Urbanus RT, Roest M, de Groot PG,. Beta2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome. Blood 2004; 104: 3598-3602.
38. Heikal NM, Jaskowski TD, Malmberg E, Lakos G, Branch DW, Tebo AE,. Laboratory evaluation of anti-phospholipid syndrome: A preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort. Clin Exp Immunol 2015; 180: 218-226.
39. Sanfelippo M, Joshi A, Schwartz S, Meister J, Goldberg J,. Antibodies to phosphatidylserine/prothrombin complex in suspected antiphospholipid syndrome in the absence of antibodies to cardiolipin or beta-2-glycoprotein I. Lupus 2013; 22: 1349-1352.
40. Hoxha A, Ruffatti A, Mattia E, et al. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome. Clin Chem Lab Med 2015; 53: 1265-1270.
41. Amengual O, Horita T, Binder W, et al. Comparative analysis of different enzyme immunoassays for assessment of phosphatidylserine-dependent antiprothrombin antibodies. Rheumatol Int 2014; 34: 1225-1230.